Synthesis and in vitro characterization of radioiodinatable benzodiazepines selective for type 1 and Type 2 cholecystokinin receptors

Keyphrases

• In Vitro Characterization 100%
• Benzodiazepines 100%
• Cholecystokinin Receptor 100%
• CCK1 Receptor 100%
• Tumor 75%
• 125I 75%
• Urea 50%
• 1-Methyl 50%
• Phenyl 50%
• Benzo 50%
• Compound 9 50%
• Receptor-binding Domain 50%
• CCK2 Receptor 50%
• Diazepin 50%
• High Affinity 25%
• Receptor Binding 25%
• Nonapeptides 25%
• Selective Labeling 25%
• Calcium Mobilization 25%
• (R)-1 25%
• Cholecystokinin 25%
• Selective Antagonist 25%
• Peptide Receptor 25%
• Radioligand 25%
• Specific Peptide 25%
• 1,4-Benzodiazepine 25%
• In Vitro Receptor Autoradiography 25%
• In Vivo Tumor Targeting 25%
• Human Tumor Tissue 25%
• Direct Labeling 25%
• Peptidic 25%

Medicine and Dentistry

• In Vitro 100%
• Neoplasm 100%
• Cholecystokinin B Receptor 100%
• Benzodiazepine Derivative 100%
• Cholecystokinin A Receptor 80%
• Iodine 125 60%
• Receptor Binding 60%
• Binding Site 40%
• Diazepam 40%
• Receptor 20%
• Autoradiograph 20%
• Radioligand 20%
• Internalization 20%
• Calcium Mobilization 20%
• Peptide Receptor 20%
• Cholecystokinin 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Cholecystokinin B Receptor 100%
• Neoplasm 100%
• Receptor 80%
• Cholecystokinin A Receptor 80%
• Iodine-125 60%
• Diazepam 40%
• Binding Site 40%
• Autoradiography 20%
• Radioligand 20%
• Cholecystokinin 20%